Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 808.5 JPY 2.31% Market Closed
Market Cap: 642.5B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note

Rohto Pharmaceutical Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Rohto Pharmaceutical Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Rohto Pharmaceutical Co Ltd
TSE:4527
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shiseido Co Ltd
TSE:4911
Additional Paid In Capital
ÂĄ73.7B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
0%
Kao Corp
TSE:4452
Additional Paid In Capital
ÂĄ106.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Kose Corp
TSE:4922
Additional Paid In Capital
ÂĄ179m
CAGR 3-Years
N/A
CAGR 5-Years
64%
CAGR 10-Years
-30%
F
Fancl Corp
TSE:4921
Additional Paid In Capital
ÂĄ12.2B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
0%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Additional Paid In Capital
ÂĄ522m
CAGR 3-Years
-50%
CAGR 5-Years
-34%
CAGR 10-Years
-19%
No Stocks Found

Rohto Pharmaceutical Co Ltd
Glance View

Market Cap
640.7B JPY
Industry
Consumer products

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. The company is headquartered in Osaka, Osaka-Fu and currently employs 6,596 full-time employees. The firm primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The firm operates its business in domestic market and overseas markets, including Europe, Asia and America.

Intrinsic Value
3 343.8 JPY
Undervaluation 16%
Intrinsic Value
Price

See Also

Back to Top